LifeStance Health Group I...

NASDAQ: LFST · Real-Time Price · USD
5.46
-0.12 (-2.15%)
At close: Aug 15, 2025, 3:45 PM

LifeStance Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.25B 1.06B 859.54M 667.51M
Cost of Revenue
848.57M 753.57M 622.52M 466M
Gross Profit
402.4M 302.1M 237.02M 201.51M
Operating Income
-31.61M -189.13M -210.17M -286.35M
Interest Income
n/a n/a n/a n/a
Pretax Income
-57.61M -206.58M -232.73M -333.11M
Net Income
-57.44M -186.26M -215.56M -307.2M
Selling & General & Admin
363.06M 410.79M 373.43M 433.73M
Research & Development
n/a n/a n/a n/a
Other Expenses
70.95M 80.44M 69.2M 54.14M
Operating Expenses
434.01M 491.23M 447.19M 487.86M
Interest Expense
26.54M 21.22M 19.93M 38.91M
Selling & Marketing Expenses
n/a n/a 8.63M n/a
Cost & Expenses
1.28B 1.24B 1.07B 953.86M
Income Tax Expense
-170K -20.32M -17.17M -25.91M
Shares Outstanding (Basic)
379.15M 367.46M 355.28M 327.52M
Shares Outstanding (Diluted)
379.15M 367.46M 355.28M 327.52M
EPS (Basic)
-0.15 -0.51 -0.61 -0.94
EPS (Diluted)
-0.15 -0.51 -0.61 -0.94
EBITDA
39.87M -104.93M -136.41M -229.62M
EBIT
-31.08M -185.36M -212.8M -294.19M
Depreciation & Amortization
70.95M 80.44M 69.2M 54.14M